Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hard to figure research and development costs in a detailed way. Roughly went from $6.4 million to about $10.4 million from 2015 to 2017. Would be higher if operating both phase 3 adequately. Queensbury site is costly and very, very important. Filter must be available, of consistent quality, meet FDA inspection standards.
My conclusion Simpson is far better at all aspects than given credit. Of course given no credit, it is a low bar to hurdle. Investors did not support the ugly convertible, so the law of gravity was in full display. Yes a few bought as investors, I did for instance
Rap is beating a dead horse, the national dcth ihub pastime. The company needs money, everybody knows that. Whether the company has been inaccurate, in filings of course. In the case of repeating a filing over and over for nearly a month where 90 days sufficient of cash was stated. Then Rap knows May 31 is not an exact date anyway. If Simpson thought the companies was going to run dry on June 30 at 10:00 am, she could dramatize accurately and say May 31 since end of June not quite.
So mostly a diversion for entertainment purposes to pull your leg
Did you own shares on the record date?
yes, we had to throw him out
An investment group might could flip as you say making use of a strong PR campaign. I would say in that case, problem solved. Wait though to see accumulation
You certainly have not made the case it can be turned on a dime. Costs to approval possibly $50 million plus and no conservative company would think before 2020 for approval.
And then what would they get for their effort, something great in revenue or something less than stellar. They are businessmen not dreamers.
Capt 370 and the later generations are of course dreamers. Businessmen probably look at $2.7 million and think we could do better. They also look at other companies, why would they be fixated on delcath
No, to begin with fda approval is more than 2 years away for little OM. So far only one country Germany provides reimbursement and not much eager beaver proof for that gem in revenue. 2 locations in the world (Southampton and a German location) must be accounting for close to 40 percent of all commercial usage.
That supposes the company is commercially attractive right now. Lots of reason to think it is not
Keep forgetting the setup prior to Hobbs was amateur hour. Then Hobbs was an egotistical kingdom builder, that was not wise enough to avoid the company from the get go. Small hearted Simpson wants to walk to the bank for the final time rolling on the sidewalk with laughter because she professionally drove the clinical side to success
The only real difference between trompete position and many others would be that he is in the camp that there is no buy out.
Actually the 8K if anything would make a buyout look pleasing to her, possibly aligning her interests with shareholders except for ...
Chemosat is not commercially attractive at this time. That is my position. She may look forward to a nice buyout as much as anybody. Possibly always has. It is too early, more dilution to come
You have to cite specific examples regarding filings. From a future viewpoint I believe the company including bod has indicated every intention of achieving a reverse split. I don't believe Ayrton Capital was blindsided with this intention
Congratulations it would seem is in order for investors not going hog wild until they can see the whites of the eyes
For forward thinking:
think another offering or buyout, if I thought it was profitable to buy on buyout speculation, I would do so.
Another offering 90 percent chance
bankrupt 7 percent
imminent b/o 3 percent
I was thinking about a short term trade today, but the spike from 8K does not look likely. The clock is ticking towards Friday week for vote.
My guess is Roth Indians see the situation still as a sell.
On one fact we can all agree Simpson's top priority is not to make you and me money. It would be an impossible task so no more purpose to the near infinite number of such posts
Purposeful posts are about vote, potential reverse split, offering. Buyout is legit to discuss, but I definitely still have to think not now
It is time to forget about compensation. You could find many companies where compensation is questionable. I daresay over 95 percent of folks here have the lowest possible regard for Simpson, why support each other endlessly
I challenge people to think outside the box, she does not have to have a heart as big as all outdoors to potentially achieve MAGICAL MAGICAL approval. If she achieves approval someday, it will be her laughing all the way to the bank and if I am lucky, me too
It does not prevent buyout, it means Simpson would probably be happy financially in all scenarios whether b/o, bankruptcy, or business as usual. So far trading seems to indicate business as usual. IF there were a bunch of yes voters, they would like to sell more shares between now and apr 6
I did not say the filing was fake, I have to blame your reading
By the way, it would provide an incentive for the company to declare bankruptcy while there would be just enough money to hand out some to the big three employees. Translation sooner rather than later.
My gut feeling though is this filing is an unnecessary head fake since some speculators will make out and some will get burned while reverse split and offering and stuff continue
The only fly in that ointment is voting NO could lead to the scenario that shareholders come out worse than anybody. Indeed Simpson did not tell anybody to vote NO. Russian Roulette where bullets are bankruptcy, b/o, or an 8K that is a head fake
The same attack as salary at heart. What stinks about this filing most though is lack of clarity. If it is routine it should be made much more clear.
If it is not routine, it should not be worded as is either.
Most of the time I am ok with company communication, not this one. In fact either way as more of a signal, why not coordinate with vote results?
People post according to what they wish. For maximum objectivity I would vote for LWE on this ... I figure he doesn't care one way or the other. Of course I may be the one who would not like the viewpoint
Read this " The parties recognize that it is in the best interests of the Company and its stockholders to provide certain benefits payable in the event of a “Qualifying Termination” (as defined below) of Executive to encourage Executive to continue in Executive’s position, although no such termination is now contemplated or foreseen, and to ensure that Executive continues to be bound by reasonable confidentiality, noncompetition, and nonsolicitation restrictions." timing is a question, but quote indicates people are just speculating, seemingly a reason would be a carrot for quote, but really a carrot vs. stick
If they are stable and happy employed at delcath, the stick is maintaining territorial piece of cake
If there is no filing for termination of vote before trading tomorrow, one should wonder how strong a signal this 8k
Don't jump the gun too much. The stock has been trading in a way to indicate nobody had imminent expectations.
I don't know if this filing has meaning.
If business continues as usual, I maintain Simpson is legitimate, an investment here is legitimate, avoid any convertible financing as that is a show stopper.
It is fair to persuade others to think along side. I believe this is a very legitimate company in the context of being highly risky in nature.
I think Simpson is more motivated than almost anybody here imagines to achieve FDA approval and to make the product as commercially attractive as she possible can.
I am a fan of facts. I may not like the facts, so why I am not long
1 . stock fair value is below one cent / $5 under current conditions
2 - fair value is imprecise and stock could go below fair value
3 - fair value could be lowered upon facts of an offering
4 - somewhere in the mix the company could run out of money, can't leave that out as a possibility
Are there facts that Simpson made personal profit from the stock collapse? Are there facts that Simpson let the stock go down (other words how could she have prevented, provide facts)
I don't need to hear about otc. Voting no was an invitation to going to otc.
There may be facts I don't want to hear, but I am reading the posts and not getting any facts so far
In fact as poor as a convertible can be including who might choose to short::: 45,000 fold increase in shares my opinion could never happen in the face of strong buying. That is a mathematical concept I am comfortable with
You want to believe the worst, I don't. Neither is proof
I guess that is it. Some folks have given up the future, so there is no interest in if Simpson does something right. It is too late for them.
It is okay to close the door on Simpson/delcath, but this game is not over. I am standing in the Long Branch watching the game with great interest.
I think it was more luck than skill for those that bought at 2 cents, unless it was somebody following a pattern like blocking reverse splits. My assumption with delcath is that was a one trick deal.
Why do a few go to great lengths to paint Simpson as black as possible, when they have already won the battle for a long time and easily.
This company may turn into a winner, that is were I need the message to go. Simpson is excellent clinically, I think it is possible she rights the ship on raising money.
If one is convinced this is sinking to the bottom, well it could well be true. I can preach both sides of the topic in the same post, and it is not circular.
It does not always work out that way. A buy in 2003 provided a tremendous return by 2010. Sometimes lucking out on a story can ruin one's perspective.
The best time to buy could be after the next offering or there may never be a good time. I have come to believe timing and luck and skill can be super important
Thanks. The information is hard to put together.
Research and development expense:
2015 6486 in thousands
2016 8448
2017 10495
The trial started Jan 2016, but 2015 would have had phase 2 trial expenses
There should be a pecking order for most important issues:
1) reverse split or the story falls off some kind of cliff
exception 500 million more authorized may be treated like a reverse split
2) next financing
3) clinical trial progress (on this I am a 100 percent fan for now, but if enrollment rate remains stalled ????
4) nobody will care so much about Simpson's character or much else if company turns the corner, why do some folks portray that items 1 through 3 are minor to their concerns
"For the year ended December 31, 2017, research and development expenses increased to $10.5 million from $8.4 million for the year ended December 31, 2016. The increase of $2.0 million is primarily due to the ongoing efforts of the FOCUS Trial which is discussed in further detail in the Current Clinical Development Program section above."
So offhand $10.5 million in 2017 for research and development. They would have spent more but NO vote limited the spending on research and development
The Queensbury facility is costly no doubt as well, but quality control of filter is important.
Where did that assessment on 10-K of yours come from. Cut and paste would be helpful
I did not read a thing in your post that was educational about phase 3. As for financing, you can dig at why it is disappointing. It is all backwards looking analysis on financing
A lot of hopes exist based on the company being legitimate. I don't think fake companies put information on clinicaltrials.gov
Fake companies don't get hearings before FDA such as in 2013.
Some pessimists even think this story may change for the better with time.
Simpson therefore is legitimate. I would prefer legitimate discussion of issues